Sort
23,748 grants matching “melanoma”
The filopodial tip complex in adhesion, migration, and signaling
$430,735Richard E Cheney · Univ Of North Carolina Chapel Hill · R01 · FY2022 · GM
Biogenesis of Melanosomes
$430,695Seth J. Orlow · New York University School Of Medicine · R01 · FY2013 · AR
EASTERN COOPERATIVE ONCOLOGY GROUP
$430,690Vanderbilt University · U10 · FY2003 · CA
Biochemistry of Melanins and Photoprotection of the Skin
$430,676Vincent J Hearing · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
The Regulation of Mammalian Pigmentation
$430,676Vincent J Hearing · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
VERMONT INBRE: LEAD INSTITUTION CORE
$430,580Judith L Van Houten · University Of Vermont & St Agric College · P20 · FY2009 · RR
Structure-Based Design of BRAF and PI3K Inhibitors
$430,348Ronen Marmorstein · Wistar Institute · P01 · FY2009 · CA
Measuring nucleotide excision repair in human populations
$430,342Laura Jane Niedernhofer · University Of Minnesota · U01 · FY2020 · ES
Regulatory mechanisms linking HSF1 protein levels and HSF1 protein activity to the alternative splicing factor SF3B1
$430,320Eric Guisbert · Florida Institute Of Technology · R15 · FY2019 · CA
(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome
$430,292Jennifer A. Wargo · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Systemic Chemotherapy of Melanoma: NMR Studies of Lonidamine & N-Mustard Activity
$430,265Jerry D Glickson · University Of Pennsylvania · R01 · FY2013 · CA
Preclinical development of WP1066, an effective inhibitor of STAT3 activation for
$430,262Raymond J Budde · Houston Pharmaceuticals, Inc. · R44 · FY2010 · AI
The integrated stress response and the microenvironment in melanoma progression
$430,251Constantinos Koumenis · University Of Pennsylvania · R01 · FY2022 · CA
Confocal line-scanning versus point-scanning for imaging human skin in vivo
$430,233Milind Rajadhyaksha · Sloan-Kettering Inst Can Research · R01 · FY2009 · EB
NG2-PG in tumor vascularization and progression
$430,197William B Stallcup · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2006 · CA
Selective inhibition of nitric oxide synthase for multiple indications
$430,064Richard B Silverman · Northwestern University · R35 · FY2021 · GM
Immunity to MHC-restricted phosphopeptides in healthy donors and cancer patients
$430,054Victor H. Engelhard · University Of Virginia · R01 · FY2014 · CA
(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome
$429,943Jennifer A. Wargo · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
Molecular ultrasound and MRI of Vascular Development. - Renewal - 1
$429,916Daniel H Turnbull · New York University School Of Medicine · R01 · FY2015 · HL
Reprogramming the pancreatic tumor microenvironment with immunotherapy
$429,841Lei Zheng · Johns Hopkins University · R01 · FY2017 · CA
An integrated polymeric carrier for subunit cancer vaccines
$429,683Suzie H Pun · University Of Washington · R01 · FY2021 · CA
Selective inhibition of nitric oxide synthase for multiple indications
$429,644Richard B Silverman · Northwestern University · R35 · FY2023 · GM
Selective inhibition of nitric oxide synthase for multiple indications
$429,644Richard B Silverman · Northwestern University · R35 · FY2022 · GM
Project 2: Combined CAR-T cell therapy
$429,640Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2024 · CA
Antigenic Determinants on HLA-B7 and -A2
$429,529Victor H. Engelhard · University Of Virginia · R01 · FY2009 · CA